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Abstract 
BACKGROUND:Potassium-(K+)-channel inhibitors may increase systemic vascular resistance 
in vasodilatory shock states.  
OBJECTIVE:The purpose of the present study was to compare the macro- and microvascular 
effects of the adenosine triphosphate-sensitive K+-channel-(K+ATP)-inhibitor glipizide and the 
non-selective K+-channel inhibitor tetraethylammonium (TEA) in ovine endotoxemicshock and 
septic shock in rats. 
DESIGN:Two randomized, controlled laboratory studies. 
ANIMALS: Thirty female sheep and forty male Sprague Dawley rats.  
SETTING: Animal research facility 
INTERVENTION: Systemic hemodynamics were analyzed in ovine endotoxemicshock with 
guideline-oriented supportive therapy. Sheep were allocated to three treatment groups for 12h: 
glipizide 10 mg·kg-1·h-1, TEA 8 mg·kg-1·h-1 or 0.9% saline. The microvascular effects of each 
drug were evaluated in septic rats (cecal ligation and puncture model) receiving a 2-hour infusion 
of each study drug: glipizide 20 mg·kg-1·h-1; TEA 50 mg·kg-1·h-1 or 0.9% saline, respectively, 
followed by intravital microscopy of villi microcirculation. 
RESULTS: Compared to the control group, glipizide infusion increased systemic vascular 
resistance index and decreased cardiac index and heart rate (HR) in sheep (p<0.05), whereas 
TEA infusion decreased HR and resulted in a decreased survival time (p=0.001). In rats, 
glipizide infusion resulted in an increase in mean arterial pressure and a decrease in HR 
compared to baseline measurement (p<0.05) without relevant effects on the villi 
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microcirculation.TEA decreased HR and decreased capillary perfusion of the villi 
microcirculation compared to the sham group (p=0.002).  
CONCLUSIONS: Selective inhibition of K+ATP-channels in ovine endotoxemic shock with 
glipizide partially restored vasomotor tone without exerting harmful effects on intestinal 
microcirculationin septic shock in rats.Contrary, non-selective K+-channel inhibition with 
TEAshowed deleterious effects in both models, includingimpaired microcirculation and 
decreased survival time. Future research on glipizide in vasodilatory shock may be warranted. 
KEYWORDS: Endotoxemic shock; microcirculation; potassium channel inhibition, septic shock.  
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Introduction 
Sepsis, a life-threatening organ dysfunction due to a dysregulated hostresponse to infection(1), 
has a persistent high mortality of 20-50% worldwide(2,3). Early death may occur as a result of 
circulatory failure and inadequate tissue perfusion in association withvasodilatory shock. 
Catecholamines(in combination with adequate fluid resuscitation) are the first line drugs for the 
treatment of vasodilatory shock in sepsis(4,5).However, they may be associated with several 
deleterious side effects especially in high doses(7,6).This “catecholamine resistant” shock 
andhigh dosages of catecholamines are independently associated with mortality(8,9,6).Therefore, 
alternative, non-adrenergic vasoconstrictors are necessary. 
Data from experimental and clinical studies strongly suggest that K+-channels play a pivotal role 
in the pathogenesis of refractory vasodilation in septic shock and endotoxemia(10,12,11).The 
purpose of the present study was therefore to compare the effects of the adenosine triphosphate-
sensitive K+-channel-(K+ATP)-inhibitor glipizide and the non-selective K+-channel inhibitor 
tetraethylammonium (TEA)on macro- and microvascular hemodynamics in endotoxemic and 
septic shock.It was hypothesized that non-selective K+-channel inhibition decreases 
norepinephrine requirements in endotoxemic shock and that selective inhibition of K+ATP-
channelsis superior to a non-selective K+-channel inhibition in stabilizing systemic 
hemodynamics without affecting microvascular perfusionin septic shock. To address these 
questions, two established animal models were used to produce complementary data 
sets.Systemic and pulmonary hemodynamics were analyzed in an endotoxemic ovine modelwith 
guideline-oriented hemodynamic therapy(14,13), whereas microvascular effects of both 
compounds were evaluated in septic rats(16,15). 
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Materials and Methods 
Animals and ethics. 
After approval by the Animal Care Committee of the State Government of North-Rhine 
Westphalia (reference numbers: 9.93.2.10.36.07.126, sheep study; and 9.93.2.10.36.07.201, rat 
study), 30 healthy adult female ewes were instrumented for continuous monitoring of 
cardiopulmonary haemodynamics using an established protocol(14,13). In addition, 40 healthy 
male Sprague Dawley rats were instrumented to perform intravital video microscopy 
(IVM)intestinal villus microcirculation according to an established protocol(16,15). Figure 1 
shows a flow diagram of the experimental protocol.  
Anesthesia,instrumentation, and monitoring of sheep. 
Sheep were instrumented under balanced anesthesia(detailed information are provided in 
supplemental digital content, http://links.lww.com/SHK/A693). Afterwards, anesthesia was 
terminated, and the awake sheep were extubated. To prevent postoperative dehydration, all sheep 
received an intravenous infusion of 20 mL·kg-1of a balanced crystalloid solution (Sterofundin® 
ISO, B. Braun Melsungen AG, Germany) over one hour following anesthesia. A 24-h period of 
recovery was allowed. 
Experimental protocol (sheep study).  
Inclusion criteria for the study were an initial heart rate (HR)<100 beats·min-1, core body 
temperature ≤39.8°C, mean arterial pressure (MAP)≥80 mmHg, mean pulmonary arterial 
pressure (MPAP)≤20 mmHg and arterial lactate ≤1.2 mmol·L-1. All measurements were 
performed in awake and spontaneously breathing animals housed in metabolic cages. 
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Following baseline measurements in the healthy state (BLsheep), 2 mL·kg-1·h-1 of balanced 
crystalloids (Sterofundin® ISO, B. Braun Melsungen, Germany) were continuously infused to 
account for basal fluid requirements. All animals received a continuous infusion of Salmonella 
typhosa endotoxin (Sigma Chemicals, Deisenhofen, Germany, Catalogue # L6386-100mg), 
which was started at a rate of 5 ng·kg-1·min-1 and doubled every hour until MAP fell below 65 
mmHg. At this time, endotoxemic shock baseline measurements (Shocksheep)were performed and 
endotoxin infusion was maintained at the respective dose. During induction of endotoxemic 
shock one animal died and was excluded from the study. If necessary, sheep received a 
continuous infusion of glucose 40% to prevent hypoglycemia starting at time point Shocksheep. 
Study therapy was immediately started afterShocksheep measurements.Therefore, the remaining 
twenty-nine sheep were randomized into three study groups and received a continuous infusion 
of the individual study drug diluted in 0.9% saline at an infusion rate of 10 mL·h-1. The 
Glipizidesheep group received 10mg·kg-1·h-1glipizide (glipizide sodium salt; Inotek 
Pharmaceuticals, Massachusetts, United States; n=10). The dose was based onprevious data in 
ovine endotoxemia(17,13).The TEAsheep groupwas treated with8 mg·kg-1·h-1 TEA 
(tetraethylammonium chloride; Sigma-Aldrich Chemie GmbH, Munich, Germany; n=9).The 
TEA dosewas based on own dose-finding experiments to reliably induce vasoconstriction in 
endotoxemic sheep. The animals of the control group (Controlsheep; n=10) received 0.9% saline 
as placebo. 
Fluid resuscitation was performed as follows: A bolus of balanced crystalloid (Sterofundin® ISO, 
20 mL·kg-1), and 6% hydroxyethyl starch solution (HES) 130/0.4 (Voluven® 6%, Fresenius Kabi 
AG, Bad Homburg, Germany) 10 mL·kg-1, were administered after Shocksheep measurement, 
followed by continuous infusions of crystalloid and HES 6%, at 12 mL·kg-1·h-1 and 3 mL·kg-1·h-
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1, respectively, throughout the duration of the experiment. If necessary, a bolus of 12 mL·kg-1 of 
crystalloid was administered to maintain a central venous pressure(CVP) of 8-12 mmHg, a 
pulmonary artery occlusion pressure (PAOP) of 12-15 mmHg and a mixed-venous oxygen 
saturation(SvO2) of ≥65%. Titration of fluid therapy was based on the Surviving Sepsis 
Campaign guidelines(19,18), which were applicable at the time of study conduction. A MAP of 
70±5 mmHg was established by continuous infusion of titrated NE, if necessary. 
Hemodynamicvariables were measured continuously and documented hourly. Blood gas 
analyses were performed hourly.At the end of the 12-h intervention period the ewes were deeply 
anesthetized with propofol (4 mg·kg-1) and killed with a lethal dose of 100 mL potassium 
chloride solution (7.45%). 
Anesthesia and instrumentation of rats.  
Forty male Sprague Dawleywere anesthetized and instrumented for cecal ligation and puncture 
(CLP) according to a standardized protocol (detailed information regarding anesthesia and 
instrumentation are provided in a supplemental digital content, 
http://links.lww.com/SHK/A693)(16,15). Thirty rats underwent CLP, whereas ten animals (in the 
following referred to as Shamrat group) underwent laparotomy without CLP. During the 
subsequent 22-h period in which peritoneal sepsis developed, animals lived in metabolic cages. 
Analgesia and fluid therapy were realized by continuous intravenous infusions of fentanyl (4 
μg·kg-1·h-1; Fentanyl Janssen; Janssen-Cilag GmbH) and 0.9% saline (6 mL·kg-1·h-1).  
Experimental protocol (rat study). 
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During the 22 hours after the CLP or sham procedure, 8 of 30 rats, who underwent CLP, and 1 of 
10 animals of the Shamrat group died. Immediately after this period of 22 hours, baseline 
measurements were performed (time point Sepsisrat)comprising MAP, HR and respiratory rate 
(RR).Thereafter the remaining 22 septic ratswere randomized into three groups based on their 
treatment over the following 2 hours:20 mg·kg-1·h-1 Glipizide (Glipiziderat group, n = 8); 50 
mg·kg-1·h-1TEA (TEArat group, n = 7)or 0.9% saline as placebo (Controlrat; n = 7). Sham animals 
also received placebo infusion (Shamrat; n = 9).The dose of glipizide was based on a previous 
study where glipizide reliablyincreased MAP in conscious rats(20), whereas the TEA dose 
wasbased on data of endotoxemic rats(21).After the 2-hour treatment period measurements of 
MAP, HR and RR were repeated (time pointTherapyrat) followed by intravital microscopy of rat 
villi microcirculation. 
Intravital microscopy of rat villi microcirculation. 
Immediately after the time point Therapyrat, rats were anesthetized by isoflurane insufflation 
(targeted expiratory fraction 1.0 %; Forene®,AbbVie Deutschland GmbH & Co. KG, 
Wiesbaden, Germany) and continuous intravenous infusion of fentanyl (4 μg·kg-1·h-1; Fentanyl 
Janssen; Janssen-Cilag GmbH). Afterwardsthey were prepared for intravital microscopy (IVM) 
and videos of rat villi microcirculation were recorded in a standardized manner (detailed 
information are provided in a supplemental digital content, 
http://links.lww.com/SHK/A693)(22,15). During the entire period of IVM the infusion of study 
drugs or vehicle, anesthesia and fluid was continued. After the end of the video recordings 
animals were killed in deep anesthesia with a lethal injection of potassium chloride (7.45%). The 
analysis of all video recordings was carried out by two independent blinded investigators after 
the end of the experiment (off-line; detailed information areprovided in a supplemental digital 
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content, http://links.lww.com/SHK/A693). In the videos of rat villi microcirculation, the 
intercapillary area (ICA) of all capillaries (ICAtotal), which is inversely correlated to capillary 
density, was determined (detailed information on the video analysis are provided in a 
supplemental digital content, http://links.lww.com/SHK/A693). As asurrogate for thefraction 
ofperfused capillaries, the ICAofcontinuouslyperfusedcapillaries(ICAcont) was determined. The 
ratio of mean ICAcont to mean ICAtotal of each animal was calculated and referred to as ratio 
ICAcont/ ICAtotal. In addition, the villus terminal arteriolar blood flow (Qterminal) was calculated 
from the diameter of the terminal arteriole (Dterminal) and the local red blood cell velocity (VRBC).  
Aims and study end points. 
The sheep study was designed to investigate the systemic effects (long-term) of glipizide and 
TEA on macrocirculation and survivalin a large animal model of endotoxemic shock with 
guideline-oriented supportive therapy. Primary study end point of the sheep study was the 
difference in NE requirements between groups. Secondary endpoints were differences in 
hemodynamics, oxygen transport variables, organ function and survival times. 
The rat study was designed to investigate the immediate (short-term) microcirculatory effects of 
glipizide and TEA on rat intestinal microcirculation. Primary end point of the rat study was the 
difference in variables of rat villus microcirculation, whereas differences in MAP, HR and RR 
were examined as secondary end points. 
Statistical analyses of both studies.  
Continuous variables were described as median (percentile 25 - percentile 75).Kruskal-Wallis 
test was used to test hypotheses relative to continuous variables. If applicable, post-hoc 
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comparisons were conducted using Dunn’s test. Comparisons between time points were made 
using Wilcoxon signed-rank test. Log-rank test was used to analyze survival among groups in the 
sheep study. 
Multivariate models of Generalized Estimating Equations (GEE)(25,23,24) were used for the 
sheep study data to compare the differences among groups in hemodynamic and metabolic 
variables throughout the duration of the experiment, assuming a linear evolution in time during 
the 12 hours after Shocksheep(detailed information regarding the use of GEE are provided in a 
supplemental digital content, http://links.lww.com/SHK/A693). 
A 0.05 level of significance was used for all hypothesis tests. Statistical analysis was performed 
with IBM SPSS® Statistics 24 (IBM, Armonk, United States). 
Results 
Results of the sheep study 
Effects of endotoxin infusion in sheep (n=29). 
After median 17 hours [8; 33] endotoxin infusion resulted ina hypodynamic shock with reduced 
MAP (p<0.001 versus BL),increase in HR (p<0.001), and decline in CI (p=0.043) due to a 
reduction in stroke volume.In addition,left ventricle stroke work index (LVSWI) (p<0.001) and 
CVP (p=0.002) decreased and animals developed fever (p<0.001).There were no differences in 
oxygen delivery or consumption with the onset of shock, whereaslactate increased. Moreover, 
endotoxin infusion resulted in metabolic acidosis with reduction in base excess (BE, p<0.001) 
and pH (p=0.001). MPAP and PVRI increased significantly (p≤0.001). There was a reduction in 
urinary output (p=0.003). Table 1 shows corresponding data to the results mentioned above. 
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Hemodynamic and metabolic effects of K+-channel inhibitors.  
The initiation of a supportive therapy with fluids and NE led to a hyperdynamic macrocirculation 
with increases in CI, HR and MAP and continuous decreases in SVRI in all three study 
groups(detailed information of the course of CI, HR, MAP and SVRI in each study group are 
provided in a supplemental digital content, http://links.lww.com/SHK/A693). This hyperdynamic 
macrocirculation was maintained throughout the duration of the experiment. There was no 
significant difference in MAP among groups during the 12-hour observation period, although 
animals in the Glipizidesheep group had an overall increased systemic vascular resistance 
index(SVRI; p=0.001; Table 2) compared to Controlsheep. Animals in both treatment groups had 
lower HR compared to Controlsheep (vs. Glipizidesheep p=0.013; vs. TEAsheep p=0.017; Table 
2).Neither the infusion rate nor the cumulative dose of NE were statistically different among 
groups, despite tendencies towards lower NE doses in the glipizide versus the control group 
(Tables 3 and 4).  
Compared to Controlsheep, glipizide infusion was associated with decreased CI (p=0.003; Table 2) 
andstroke volume index (SVI) (p=0.008; Table 2). Oxygen delivery (p=0.019; Table 3) and 
consumption (p=0.003; Table 3) were decreased in the Glipizidesheep group compared to 
Controlsheep with no difference in oxygen extraction ratio (O2ER) or SvO2 (Table 3).TEA infusion 
was associated with increased oxygen consumption (vs. Glipizidesheep; p=0.005; Table 3) with no 
difference in oxygen delivery compared to Glipizidesheep and Controlsheep, but a greater O2ER 
(p=0.010; Table 3) in comparison to the Glipizidesheep group. Additionally, the SvO2 was lower in 
the TEAsheep group compared to Glipzidesheep (p=0.002)and Controlsheep (p=0.011; Table 3). 
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Diuresis, plasma lactate and glucose were not different between groups during the entire time of 
the experiment (Table 3). Nevertheless, animals of the TEAsheep group showed an increase in BE 
compared to Controlsheep (p=0.005) and Glipizidesheep (p=0.002; Table 3). 
Fluid infusion 
There were no differences in the amount of crystalloid and colloid solutions per kilogram body 
weight and hours survival time when comparing groups of the sheep study (Table 4). In addition, 
the total volume infused per kilogram body weight and hours survival time between the 
groupsdid not differ between groups (Table 4).  
Survival time 
Animals in the TEAsheep group had a reduced survival time (5.0 hours [4.1-5.9]) compared to 
Controlsheep (9.0 hours [6.8-11.3]) with no animal reaching the end of the 12-hour intervention 
period (p=0.001; Figure 2). Average survival time did not differ between Glipizidesheep (8.0 hours 
[6.5-9.5]) and Controlsheep (p=0.452). In addition, cumulative dosage of endotoxin did not differ 
between groups (Table 4). 
Results of the rat study 
There were no relevantbaseline differences in any of the investigated variables at the 
timepointSepsisratamong the Controlrat, Glipiziderat and TEArat groups. The Shamrat group had a 
lower HR (Table 5). 
Hemodynamic effects of K+-channel inhibitors. 
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Infusion of glipizide resulted in an increase in MAP compared to Sepsisratmeasurement 
(p=0.012; Table 5and Supplemental figure 6, http://links.lww.com/SHK/A693). Both, glipizide 
and TEA, led to a reduction in HR (p<0.05 each; Table 5and Supplemental figure 6, 
http://links.lww.com/SHK/A693). RR did not change in any of the study groups (Table 5). In 
addition, all hemodynamic variables were stable over time in the Shamrat group (Table 5). 
Effects of K+-channel inhibitors on villi microcirculation.  
Neither ICAtotal, nor ICAcont or the ratio ICAcont/ ICAtotal of the Glipiziderat group differed 
significantly from the Shamrat group or Controlrat group (Table 6). However, the ICAtotal and the 
ICAcont were increased in the animals of the TEArat group compared to the Shamrat group 
(p=0.035 and p=0.002; Table 6). In addition, the ratio ICAcont/ ICAtotalwas higher in the TEArat 
group compared to the Glipiziderat (p=0.013) and the Shamrat group (p=0.012; Table 6 and Figure 
3). 
Discussion 
The major findings of the present study are thatin ovine endotoxemic shockcontinuous 
intravenous infusions of theK+-channel inhibitors glipizide and TEA are not associated with a 
reduction in NE requirements compared to standard treatment with NE. Nevertheless,the 
selective K+ATP-inhibitor glipizide stabilized systemic hemodynamics (as indicated by an 
increased SVRI and a reduced HR), whereas the non-selective K+-channel inhibitor TEA was 
associated with anincreased oxygen consumption and reduced survival time in ovine 
endotoxemic shock. Moreover, glipizide increased MAPwithout affecting the intestinal 
microcirculation in the rat septic shock model. Contrary, TEA resulted in a deterioration of rat 
villous microcirculationand exerted no statistical effects onMAP. 
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Administration of vasopressors in septic shock aims to maintain perfusion pressure by increasing 
SVRI and, thereby, to restore tissue perfusion. Microcirculatory alternations are frequent in 
sepsis, however, they do not necessarily correlate with macrohemodynamic changes(26). 
Because vasopressors carry the risks of excessive vasoconstriction and tissue hypoperfusion it is 
crucial to investigate their effects on the macro- and microcirculation(27). In the present study 
this was achieved by combining two models of endotoxemic and septicshock. Focusing on 
macrocirculatory parameters, previous trialsrevealed that intravenous bolus infusions of 
sulfonylureas, like glipizide, increased MAP and SVRI in experimental septic 
shock(17,28).However, experimental und clinical data suggest that bolus infusions of 
sulfonylureas in septic shock mediate no long-lasting effect on vascular tone(17,28,30,29).In this 
context, Lange et al. demonstrated that a continuous infusion of glipizide offers a longer-lasting 
effect on macrohemodynamicsin endotoxemic sheep(13).In the present study a continuous 
infusion of glipizide for 12h partially restored vasomotor tone in endotoxemic sheep, as indicated 
by an increase in SVRI. Nevertheless, the glipizideinfusionhad nosignificant effect on NE 
requirements. There are manifold potential explanations: It is known that the profound 
vasoplegia in septic shock is mediated not only by K+ATP-channels(12,32,31), but also by 
increases in NOproduction and potentially vasopressin deficiency, for example. Thus, selective 
K+ATP-channel inhibition alone might not always be sufficient to reduce NE requirements. On the 
other hand, it could be hypothesized that the guideline-oriented therapy with adequate fluid 
resuscitation masked potential differences in NE requirements. This assumption is supported by 
a tendencytowards lower NE requirements in the Glipizidesheep group, overall low NE 
requirements and large amounts of administered fluids in all three groups.  
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Contrary, TEA did not restore vascular tone in experimental endotoxemic and septic shock, but 
resulted in premature death of all TEA-treated sheep. Notably, TEA can induce neurotoxic 
effects by blocking autonomic ganglia. The observed reduction in HR in both studies after TEA 
infusion is likely due to its ganglion blocking properties(33). Although it lacks objective 
measurements, premortal animals in TEAsheep group were agitated, a potential clinical sign of 
neurological toxicity. These unanticipated results stand in contrast to previously published 
studies, in which TEA counteracted sepsis-induced hypotension in small animals(32) or restored 
the vasopressor-response in human experimental endotoxemia and experimental sepsis in small 
animals(11,31).In this context, Sordi et al. previously reported the effects of two different TEA 
dosages in septic rats. A single low dose of TEA (8 mg·kg−1; SC) stabilized hemodynamics, 
whereas a higher dose (16 mg·kg−1; SC)was associated with an increased mortality(32).It can be 
speculated that the dose administered to sheep was excessive. However, previously performed 
dose-finding studies did not show the high mortality observed after 12-hours of TEA-infusion, 
which could be explained by ashorter observation period.  
The infusion of glipizide was associated with a decrease in HR, CI, DO2I and VO2I in 
endotoxemic sheep.In addition to the findings of Lange et al., who attributed a similar 
observation to a baroreceptor reflex following an increase in SVRI(13), a significant decrease in 
SVI occurred in glipizide-treated sheep. It is most likely that the reduction in SVI is due to an 
elevation in SVRI, which may represent an increased left ventricular afterload. Notably, 
decreases in CI and DO2I may compromise cellular oxygenation when falling below critical 
values. However, values of CI were supraphysiologic in all groups after supportive treatment 
with fluids and NE. Moreover, no signs of tissue hypoperfusion were observed, as indicated by 
BE, lactate or SvO2, which were all maintained.As a sulfonylurea, glipizide may have the ability 
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to decrease blood glucose concentrations and hypoglycemia is known to be deleterious in critical 
illness. However, the current study found no statistical differences between the groups of the 
sheep study in blood glucose concentrations during the experimental period.Taken together,no 
detrimental or unexpected effects of glipizidein the rat and sheep study were found.  
In the present sheep study, TEA was associated with an increased oxygen consumption and a 
drop in SvO2. This may suggests an elevated oxygen demand, which is potentially deleterious in 
septic shock, where the oxygen utilization is per se impaired (34). 
One relevant aspect of septic shock is that hypoperfusion of the intestinal microcirculation may 
contribute to translocation of bacteria, proteases, and toxins from the gut to the systemic 
circulation via breakdown of the gut barrier function. This may facilitate remote systemic 
complications in critically ill patients(35). This intestinal hypoperfusion may be aggravated by 
exogenous vasoconstrictors, which are commonly used in septic shock patients. In the present 
study, glipizide infusion increased MAP in septic rats, without compromising intestinal 
microcirculatory perfusion variables. These results challenge a previous report from Beck et al., 
who examined the effect of the sulfonylurea glibenclamide in septic rats. The latter study did not 
describe any effects of a single glibenclamide boluson macro- and microcirculatory 
variables(36). However, the dose of glibenclamide was much lower than the respective dose of 
glipizide in the current study and, thus, may not be sufficient to increase MAP in rats. In 
contrast,TEA infusion resulted in adeterioration of rat villi microcirculation, with more than 50% 
increase in ICAcont, corresponding to a decreased capillary perfusion. It is likely that the increase 
in ICAcont is due toedemaformation rather than an excessive vasoconstriction. This is supported 
by the fact that neither Dterminal and VRBC nor MAP exerted a significant change associated with 
TEA infusion. In addition, animals of the TEArat group showed macroscopically pronounced 
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ascites and bowl edema. This observation is in accordance with toxicity studies describing the 
development of edema after lethal and sublethal doses of TEA(37). 
Limitations of the study. Apotential limitation of the sheep study is the initiationof 
shockbyendotoxin infusionwhich does not entirelyreflect human sepsis.However,due to its 
excellent standardizationandthe similarity tohemodynamicchangesinhuman vasodilatory shockit 
representsan internationally establishedmodel(14,17,13,38).A further limitation of the sheep 
study is that HES solutionswere used for fluid resuscitation, which arecontra-indicated at present 
in critically ill patients due to suspected  increasesin renal failure(4,5).Notably, fluid therapy was 
based on the Surviving Sepsis Campaign guidelines, which were applicable at the time of study 
conduction andrecommended HES solutions as well as the use of static preload variablesin septic 
shock(19,18).Since fluid resuscitation was performed with the same protocol in all study groups, 
it should not impact on the effects of the study drugs.When interpreting the present data, it is 
important to note, that the pathophysiology of ovine endotoxemic shock and septic shock in rats 
differ significantly. A direct comparison of both models may be not valid, and, therefore, both 
studies should be viewed rather complementary than comparative.Moreover, the study drug 
doses were markedly different between the rat and the sheep study (especially the TEA dose). 
However, doses were derived from the published literature on this drug in the respective species. 
Nevertheless, it may be hypothesized that the TEA dose in rats was relatively high, which may 
have facilitated the negative effects on gut microvascular perfusion.Finally, microcirculatory 
perfusion in sepsis depends on multiple factors like volume therapy, or origin of sepsis, and, 
thus, an intact intestinal microcirculation not inevitably indicates the global absence of 
microcirculatory disturbances in the individual case. 
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Conclusion 
This study demonstrates that selective inhibition of K+ATP-channels in vasodilatory shock by 
continuous infusion of glipizide couldpartially restorevasomotor tone in endotoxemic sheepand 
improve systemic hemodynamics in septic rats without exerting harmful effects on intestinal 
microcirculation. In contrast, non-selective K+-channel inhibition by TEAfailed to exert 
beneficial effects on systemic macro- and micro-hemodynamicsin alarge animal 
modelofendotoxemicshock and in septicrats.In contrast, TEAdecreased average survival time in 
endotoxemicsheep andresulted in a deterioration ofvillous microcirculation in septic rats. 
Furtherexperimental studies, evaluating the effectsand the optimal treatment regime of selective 
K+-channel inhibitorsmay be warranted to identify potential settings in which glipizide may 
improve relevant outcome variables. 
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Figure legends 
Figure 1  Experimental protocol of the sheep and rat study. 
Animals in animal care facility
A. Instrumentation
B. Shock induction
C. Therapy
Sheep Study
Controlsheep Glipizidesheep TEAsheep
30 female sheep 40 male Sprague Dawley rats
+
Rat Study
arterial catheter, pulmonary 
artery catheter, urinary catheter
Infusion of endotoxin                   
(5 ng·kg-1·min-1, doubled every 
hour until MAP <65 mmHg)
Healthy baseline measurent 
(time point BLsheep)
endotoxemic shock            
shock measurements (time point 
Shocksheep) and randomisation
guideline-oriented supportive therapy 
CLP
Jugular and carotid catheter
Controlrat Glipiziderat TEArat
septic measurements               
(time point Sepsisrat)                         
and randomization
2-hour treatment period measurements                    
(time point Therapyrat)
Sham laparotomy
0.9% saline
Figure 1 Experimental protocol of the sheep and rat study
 
 
  
Copyright © 2018 by the Shock Society. Unauthorized reproduction of this article is prohibited.
 
 
Figure 2  Kaplan-Meier survival curves (sheep study). 
The TEAsheep group had a significantly (*) reduced survival (5.0 hours [4.1-5.9]) 
compared to the Controlsheep group (9.0 hours [6.8-11.3]; p=0.001). Survival time 
did not differ between Glipizidesheep (8.0 hours [6.5-9.6]) and Controlsheep group. 
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Figure 3 Effects of K+-channel inhibitors on the intestinal microcirculation after the 
two-hour intervention period (rat study).  
Data arepresentedas box plots. Intercapillary area size (ICAtotal; A), Intercapillary 
area size of continuously perfused capillaries (ICAcont; B), Ratio of intercapillary 
area size of continuously perfused capillaries and total intercapillary area size 
(ratio ICAcont/ ICAtotal; C). § indicates a significant difference (p<0.05) vs. TEArat;    
indicates a statistical outlier in the presentation of the data as box plots. 
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Table 1 
Hemodynamics, variables of oxygen transport, metabolism and organ function at 
baseline and shock (sheep study). 
Variable [Unit] BLsheep Shocksheep P Value 
Hemodynamics       
HR [beat·min-1] 90 [80; 98] 120 [106; 132] <0.001 * 
MAP [mmHg] 89 [86; 93] 64 [63; 65] <0.001 * 
SVRI [dyne·s·cm-5·m-2] 1255 [1061; 1519] 1096 [896; 1292]  0.008 * 
SVI [mL·beats-1·m-2] 61 [55; 65] 38 [32; 47] <0.001 * 
CI [L·min-1·m-2] 5.2 [4.6; 6.1] 4.5 [4.0; 5.6] 0.041 * 
CVP [mmHg] 5 [4; 9]  3 [2; 4]  0.002 * 
LVSWI [g·m-1·m2] 67 [63; 72] 30 [26; 34] <0.001 * 
RVSWI [g·m-1·m2] 8 [7; 10] 9 [7; 10] 0.397 
MPAP [mmHg] 16 [15; 18] 20 [17; 24]  0.001 * 
PVRI [dyne·s·cm-5·m-2] 129 [81; 156] 204 [140; 316] <0.001 * 
PAOP [mmHg] 8 [6; 11] 8 [4; 12] 0.990 
Oxygen transport variables   
Hct [%] 30 [27; 35] 35 [33; 41] <0.001 * 
SvO2 [%] 68 [63; 69] 67 [61; 70] 0.462 
DO2I [mL·min-1·m-2] 663 [569; 771] 701 [616; 774] 0.888 
VO2I [mL·min-1·m-2] 210 [164; 241] 205 [157; 220] 0.098 
O2ER [%] 30 [27; 35] 28 [25; 34] 0.127 
Metabolic variables and organ function    
BE [mmol·L-1] 2.2 [1.3; 3.2] 0.5 [-1.8; 1.7] <0.001 * 
pH [-log10(H+)] 7.46 [7.43; 7.50] 7.42 [7.38; 7.46] 0.001 * 
Lactate [mmol·L-1] 0.8 [0.6; 0.9] 2.9 [2.4; 4.0] <0.001 * 
 
PaO2/FiO2 [mmHg] 
491.4 [475.2; 
518.1] 
489.5 [445.7; 511.4] 0.032 * 
Temperature [°C] 39.7 [39.5; 39.7] 41.2 [40.8; 41.6] <0.001 * 
Glucose [mg·dL-1] 78 [71; 89] 91 [81; 96] 0.011 * 
  Diuresis [mL·h-1] 56 [40; 65] 27 [12; 44] 0.003 * 
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Data are presented as median [interquartile range].  Paired-samples Wilcoxon test was used to 
compare variables between BLsheep and Shocksheep; * indicates a statistical significant difference 
(p<0.05). 
Abbreviation: BE, base excess; CI, cardiac index; CVP, central venous pressure; DO2I, oxygen 
delivery index; Hct, hematocrit; HR, heart rate; LVSWI, left ventricle stroke work index; MAP, 
mean arterial pressure; MPAP, mean pulmonary arterial pressure; O2ER, oxygen extraction 
ratio; PAOP, pulmonary artery occlusion pressure; pH, potentiahydrogenii; PaO2/ FiO2, 
oxygenation index (Horowitz); PVRI, pulmonary vascular resistance index; RVSWI, right 
ventricle stroke work index; SvO2,mixed venous oxygen saturation; SVI, stroke volume index;  
SVRI, systemic vascular resistance index; VO2I, oxygen consumption index.  
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Table 2 
Differences of hemodynamic variables among groups (sheep study). 
Variable [Unit] Group Variation vs. Controlsheep 
Variation vs. 
Glipizidesheep 
HR [beat·min-1] 
Glipizidesheep -11 [-19; -2] * - 
TEAsheep -13 [-24; -2] * -2 [-12; 8] 
MAP [mmHg] 
Glipizidesheep 2 [-3; 8] - 
TEAsheep -3 [-9; 4] -5 [-11; 1] 
SVRI [dyne·s·cm-5·m-2] 
Glipizidesheep 246 [99; 394] * - 
TEAsheep 85 [-68; 238] -161 [-346; 23] 
SVI [mL·beats-1·m-2] 
Glipizidesheep -8 [-15; 0] * - 
TEAsheep 0 [-8; 8] 7 [-1; 15] 
CI [L·min-1·m-2] 
Glipizidesheep -1.49 [-2.55; -0.42] * - 
TEAsheep -0.85 [-1.91; -0.22] 0.64 [-0.33; 1.6] 
CVP [mmHg] 
Glipizidesheep -2 [-5; 0] * - 
TEAsheep -1 [-3; 2] 2 [-1; 4] 
LVSWI [g·m-1·m2] 
Glipizidesheep -3 [-10; 4] - 
TEAsheep 0 [-8; 7] 3 [-4; 10] 
RVSWI [g·m-1·m2] 
Glipizidesheep 1 [-2; 4] - 
TEAsheep 3 [1; 6] * 2 [-1; 5] 
MPAP [mmHg] 
Glipizidesheep 0 [-4; 5] - 
TEAsheep 3 [-2; 7] 3 [-2; 7] 
PVRI [dyne·s·cm-5·m-2] 
Glipizidesheep 47 [-116; 109] - 
TEAsheep 51 [-22; 125] 5 [-70; 79] 
PAOP [mmHg] 
Glipizidesheep 0 [-3; 2] - 
TEAsheep 1 [-2; 3] 1 [-2; 4] 
 
Data are presented as average difference vs. control during 12-hour observation [CI95%]. 
Multivariate analysis using generalized estimating equations were used to compare variables of 
interest; with dependent variable: variable of interest; independent variables: time (1 hour to 12 
hours after Shocksheep), dose of norepinephrine [µg·kg-1·min-1], study group, value of variable of 
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interest at BLsheep. * indicates a significant difference (p<0.05) vs. Controlsheep; # indicates a 
significant difference (p<0.05) vs. Glipizidesheep. 
Abbreviations: CI, cardiac index; CVP, central venous pressure; HR, heart rate; LVSWI, left 
ventricle stroke work index; MAP, mean arterial pressure; MPAP, mean pulmonary artery 
pressure; PAOP, pulmonary artery occlusion pressure; PVRI, pulmonary vascular resistance 
index; RVSWI, right ventricle stroke work index; SVI, stroke volume index; SVRI, systemic 
vascular resistance index. 
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Table 3 
Differences of oxygen transport variables, metabolic variables, organ function and 
infusion rate of norepinephrine among groups (sheep study). 
Variable [Unit] Group Variation vs.  Controlsheep 
Variation vs.  
Glipizidesheep 
Hct [%] 
Glipizidesheep 0 [-3; 3] - 
TEAsheep 0 [-3; 3] 0 [-3; 3] 
SvO2 [%] 
Glipizidesheep 2 [-4; 7] - 
TEAsheep -9 [-15; -2] * -10 [-17; -4] # 
DO2I [mL·min-1·m-2] 
Glipizidesheep -221 [-380; -61] * - 
TEAsheep -142 [-327; 43] 79 [-63; 221] 
VO2I [mL·min-1·m-2] 
Glipizidesheep -74 [-122; -25] * - 
TEAsheep -3 [-57; 51] 71 [21; 120]# 
O2ER [%] 
Glipizidesheep -4 [-9; 2] - 
TEAsheep 6 [-1; 12] 9 [2; 16]# 
BE [mmol·L-1] 
Glipizidesheep -0.3 [-3.0; 2.4] - 
TEAsheep 3.4 [1.1; 5.8] * 3.7 [0.8; 6.6]# 
pH [-log10(H+)] 
Glipizidesheep -0.01 [-0.06; 0.03] - 
TEAsheep 0.00 [-0.05; 0.05] 0.02 [-0.03; 0.06] 
Lactate [mmol·L-1] 
Glipizidesheep 0.3 [-1.0; 1.6] - 
TEAsheep -0.5 [-1.8; 0.7] -0.8 [-1.7; 0.0] 
PaO2/FiO2 [mmHg] 
Glipizidesheep -13 [-52; 26] - 
TEAsheep -17 [-58; 23] -4 [-55; 47] 
Temperature [°C] 
Glipizidesheep -0.3 [0.7; 0.1] - 
TEAsheep -0.6 [-1; -0.1]* -0.3 [-0.7; 0.2] 
Glucose [mg·dL-1] 
Glipizidesheep 5.6 [-5.0; 16.2] - 
TEAsheep 0.6 [-8.2; 9.4] -5.0 [-14.6; 4.6] 
Diuresis [mL·h-1] 
Glipizidesheep 81 [-29; 190] - 
TEAsheep 46 [-86; 177] -35 [-194; 124] 
Norepinephrine infusion   
[µg·kg-1·min-1] 
Glipizidesheep 
-0.266 [-0.548; 
0.015] - 
TEAsheep -0.084 [-0.380; 0.182 [-0.033; 0.397] 
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0.212] 
 
Data are presented as average difference vs. control during 12-hour observation [CI 95%]. 
Multivariate analysis using generalized estimating equations were used to compare variables of 
interest; with dependent variable: variable of interest; independent variables: time (1 hour to 12 
hours after Shocksheep), dose of norepinephrine [µg·kg-1·min-1], study group, value of variable of 
interest at Baselinesheep. * indicates a significant difference (p<0.05) vs. Controlsheep; # indicates a 
significant difference (p<0.05) vs. Glipizidesheep. 
Abbreviations: BE, base excess; DO2I, oxygen delivery index; Hct, hematocrit; O2ER, oxygen 
extraction ratio; PaO2/ FiO2, oxygenation index (Horowitz); pH, potentia hydrogenii; SvO2,mixed 
venous oxygen saturation; VO2I, oxygen consumption index. 
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Table 4 
Cumulative fluid infusion and cumulative norepinephrine and endotoxin dose (sheep 
study). 
 
 Group 
 
Variable (Unit) Controlsheep Glipizidesheep TEAsheep 
Colloid (mL·kg-1·h-1) 3 [3; 4] 3 [3; 4] 4 [3; 4] 
Crystalloid (mL·kg-1·h-1) 20 [16; 23] 20 [18; 26] 26 [18; 27] 
Total volume infused (mL·kg-1·h-1) 27 [24; 30] 27 [25; 35] 35 [27; 39] 
Norepinephrine(µg·kg-1·h-1) 0.15 [0.09; 0.57] 0.06 [0.00; 0.08] 0.16 [0.00; 0.29]
Endotoxin (mg·kg-1·h-1) 0.08 [0.02; 0.12] 0.05 [0.02; 0.08] 0.04 [0.02; 0.05] 
Glucose infusion (mg·kg-1·h-1) 0.9 [0.7; 1.1] 1.1 [1.0; 1.3] 1.1 [1.1; 1.4] 
 
Values are presented as median [interquartile range] for each group.                                             
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Table 5 
Hemodynamic variables before and after intervention (rat study). 
   Time point 
Group n Variable [Unit] Sepsisrat Therapyrat 
Shamrat 9 
MAP [mmHg] 
124 [114; 132] 125 [119; 129] 
Controlrat 7 130 [123; 134] 131 [121; 133] 
Glipiziderat 8 119 [114; 139] 135 [130; 149] * 
TEArat 7 118 [114; 127] 119 [113; 130] 
Shamrat 9 
HR [beats·min-1] 
366 [348; 396] § 420 [348; 468] 
Controlrat 7 418 [384; 480] 444 [348; 468] 
Glipiziderat 8 474 [444; 498] 432 [396; 486] * 
TEArat 7 492 [462; 504] 408 [378; 456] # 
Shamrat 9 
RR [breaths·min-1] 
95 [87;113] 90 [82;100] 
Controlrat 7 112 [84; 150] 102 [64; 130] 
Glipiziderat 8 115 [87; 140] 113 [109; 144] 
TEArat 7 140 [125; 152] 120 [103; 126] 
 
Values are presented as median [interquartile range]. * p<0.05 vs. time point Sepsisrat; § p<0.05 
vs. time point Sepsisrat of the Glipiziderat group and vs.time point Sepsisrat of the TEArat group;# 
p<0.05 vs. time point Sepsisrat. 
Abbreviations: HR,heart rate; MAP, mean arterial pressure; RR, respiratory rate.  
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Table 6 
 
Effect of K+-channel inhibitors on villi microcirculation variables after the two-hour 
intervention period (rat study). 
 Group 
Variable [Unit] Shamrat Controlrat Glipiziderat TEArat 
ICAtotal [µm2] 
1312 
[1191; 1541] 
1532 
[1434; 1671] 
1464 
[1404; 1897] 
1693 * 
[1564; 1828] 
ICAcont [µm2] 
1812 
[1725; 1995] 
2161 
[2115; 2748] 
2091 
[1807; 2427] 
4424 * 
[3212; 5541] 
Ratio ICAcont/ ICAtotal 
1.3 
[1.3; 1.4] 
1.6 
[1.5; 1.7] 
1.3 
[1.2; 1.4] 
2.6 *, § 
[2.0; 3.0]  
Dterminal [μm] 5.6 [5.0; 6.2] 
5.2 
[4.7; 6.0] 
5.6 
[4.5; 6.15] 
5.4 
[5.0; 5.9] 
VRBC [µm·min-1] 
970 
[742; 1364] 
883 
[674; 985] 
775 
[622; 964] 
842 
[717; 845] 
Qterminal [µL·min-1] 
23.6 
[15.5; 31.3] 
14.9 
[12.0; 24.6] 
19.4 
[15.6; 21.7] 
21.1 
[17.6; 21.5] 
 
Values are presented as median [interquartile range]. *p<0.05 vs. Shamrat; §p<0.05 vs. 
Glipiziderat. 
Abbreviations: Dterminal,diameter of the terminal arteriole; ICAcont,intercapillary area size of 
continuously perfused capillaries; ICAtotal,intercapillary area size of all capillaries; 
Qterminal,terminal arteriolar blood flow; VRBC,red blood cell velocity. 
 
 
 
 
